Sunflower Pharmaceutical Group Co.,Ltd
Sunflower Pharmaceutical Group Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in 2001, the company has established itself as a leader in the development and manufacturing of high-quality pharmaceutical products, including innovative generics and specialty medications. With a commitment to research and development, Sunflower Pharmaceutical Group focuses on areas such as oncology, cardiology, and neurology, offering unique formulations that cater to diverse patient needs. The company’s dedication to quality and compliance has earned it a strong market position, recognised for its contributions to healthcare advancements. Through strategic partnerships and a robust distribution network, Sunflower continues to expand its reach, making significant strides in improving global health outcomes.
DitchCarbon Score
How does Sunflower Pharmaceutical Group Co.,Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sunflower Pharmaceutical Group Co.,Ltd's score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sunflower Pharmaceutical Group Co.,Ltd's reported carbon emissions
Sunflower Pharmaceutical Group Co., Ltd, headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As of now, Sunflower Pharmaceutical Group Co., Ltd has not inherited any emissions data from a parent or related organization, nor does it appear to be part of any significant climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). In the context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and climate commitments. However, without specific data or targets, it is unclear how Sunflower Pharmaceutical Group Co., Ltd plans to address its carbon footprint or contribute to broader climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sunflower Pharmaceutical Group Co.,Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
